1 | TNFRSF9, TNFSF9
|
| The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.
|
| Barao I.
|
| Front Immunol 3:402. doi: 10.3389/fimmu.2012.00402. eCollection 2012.
2013
|
2 | PRDM1, TNFSF9
|
| PRDM1 is a tumor suppressor gene in natural killer cell malignancies.
|
| Küçük C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G, Au WY, McKeithan TW, Chan WC.
|
| Proc Natl Acad Sci U S A 108(50):20119-24. Epub 2011 Dec 5.
2011
|
3 | CD27, CD70, TNFRSF25, TNFRSF4, TNFRSF9, TNFSF15, TNFSF4, TNFSF9
|
| The role of TNF superfamily members in T-cell function and diseases.
|
| Croft M.
|
| Nat Rev Immunol 9(4):271-85. Review.
2009
|
4 | TNFSF9
|
| CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response.
|
| Lippert U, Zachmann K, Ferrari DM, Schwarz H, Brunner E, Mahbub-Ul Latif AH, Neumann C, Soruri A.
|
| Eur J Immunol 38(4):1024-32. Erratum in: Eur J Immunol. 2008 Jun;38(6):1767. PMID: 18395851 2008
|
5 | TNFSF9
|
| Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
|
| Habib-Agahi M, Phan TT, Searle PF.
|
| Int Immunol 19(12):1383-94. Epub 2007 Oct 31.
2007
|
6 | TNFSF9
|
| Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival.
|
| Ek S, Björck E, Högerkorp CM, Nordenskjöld M, Porwit-MacDonald A, Borrebaeck CA.
|
| Int J Cancer 118(8):2092-7.
2006
|
7 | TNFSF9
|
| Expression of CD137 and CD137 ligand in colorectal cancer patients.
|
| Dimberg J, Hugander A, Wågsäter D.
|
| Oncol Rep 15(5):1197-200.
2006
|
8 | TNFSF9
|
| Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
|
| Liu GZ, Gomes AC, Putheti P, Karrenbauer V, Kostulas K, Press R, Hillert J, Hjelmström P, Gao XG.
|
| Scand J Immunol 64(4):412-9.
2006
|
9 | TNFSF9
|
| Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis.
|
| Jung HW, Choi SW, Choi JI, Kwon BS.
|
| Exp Mol Med 36(1):13-22.
2004
|
10 | TNFSF9
|
| Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2.
|
| Reali C, Curto M, Sogos V, Scintu F, Pauly S, Schwarz H, Gremo F.
|
| J Neurosci Res 74(1):67-73.
2003
|
11 | TNFSF9
|
| 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
|
| Wen T, Bukczynski J, Watts TH.
|
| J Immunol 168(10):4897-906.
2002
|
12 | TNFSF9
|
| 4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells.
|
| Kim YJ, Li G, Broxmeyer HE.
|
| J Hematother Stem Cell Res 11(6):895-903.
2002
|
13 | TNFSF9
|
| Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.
|
| Salih HR, Schmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, Nuessler V, Kiener PA.
|
| J Immunol 167(7):4059-66.
2001
|
14 | TNFSF9
|
| Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
|
| Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA, Kiener PA.
|
| J Immunol 165(5):2903-10.
2000
|
15 | TNFSF9, TNFRSF9
|
| Molecular cloning of a ligand for the inducible T cell gene 4-1BB : a member of an emerging family of cytokines with homology to tumor necrosis factor.
|
| Goodwin RG, et al.
|
| Eur J Immunol 23 : 2631-2641. 1993
|